Choosing the Best Amorphous Dispersion Path Before It Costs You

AustinPx examines why early amorphous solid dispersion (ASD) technology selection can have a major impact on cost, timelines, and long-term product value. As more oral small molecules face poor solubility, low exposure, food effect risk, and dose form challenges, a single technology screen may not provide enough information to choose the strongest development path. The whitepaper explores how evaluating spray drying, hot melt extrusion, and KinetiSol™ Technology in parallel can help sponsors avoid costly rework, wasted API, vendor delays, and late-stage formulation setbacks. It also highlights AustinPx’s unique ability to screen and develop all three leading ASD technologies under one roof, giving sponsors one expert team, clearer data comparison, and a more efficient path to a developable formulation strategy.